Autism spectrum disorder, Attention-deficit/hyperactivity disorders
Conditions
Interventions
Developmental disorders: Measurement of prefrontal cortex oxy-Hb concentration during executive functional activating / non-activating switching task performance in ASD /ADHD patients.The measuremen
Sponsors
SHIONOGI &CO., LTD
Nihon University, College of Industrial Technology, Department of Mechanical Engineering.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Developmental disorders: Those who voluntary participate in the study, with no history of treatment with psychotropic drugs. Those who are diagnosed as ASD or ADHD. Those who scored 12 points or up by ADHD-RS-IV. Typically developed: Those who are not diagnosed as developmental disorders.
Exclusion criteria
Exclusion criteria: Developmental disorders: Those who takes ADHD remedy. Typically developed: Those who are suspected as developmental disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We measure oxy-Hb, deoxy-Hb, and total-Hb, using wearable NIRS, and the data will be processed to evaluate the activation-deactivation pattern of the prefrontal cortex. Also we will ask the participants to fill out the questionnaire to confirm the psychological status of their disorders. Collected data will be analyzed within 6 months from the measurement. | — |
Countries
Japan
Contacts
Public ContactMasahito Higashiura
SHIONOGI &CO., LTD Biomarker R6D Department
Outcome results
None listed